|
Duloxetine vs. active comparator for the treatment of depression Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Duloxetine vs. active comparator for the treatment of depression conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Duloxetine vs. active comparator for the treatment of depression Clinical research trials and Duloxetine vs. active comparator for the treatment of depression health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Duloxetine vs. active comparator for the treatment of depression. Duloxetine vs. active comparator for the treatment of depression Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Duloxetine vs. active comparator for the treatment of depression clinical trial. Participants oftentimes recieve the most expert healthcare available for their Duloxetine vs. active comparator for the treatment of depression condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Duloxetine vs. active comparator for the treatment of depression  Duloxetine vs. active comparator for the treatment of depression
Duloxetine vs. active comparator for the treatment of depression
For Condition: Depression
Status: Recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: How duloxetine compares to a medication currently available for the treatment of depression in the treatment of patients with major depressive disorder. The safety of duloxetine and any side effects that might be associated with it.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - must be at least 18 years of age - must be diagnosed with depression - must sign informed consent Exclusion Criteria: - women who can become pregnant must be using birth control - previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder - history of substance abuse or dependence in the last year - patients who are suicidal - frequent or severe allergic reactions with multiple medications
Total Enrollment:
Location and Contact Information:
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Calgary, Alberta,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Sherbrooke, Quebec,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Halifax, Nova Scotia,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Ottawa, Ontario,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Victoria, British Columbia,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Burlington, Ontario,
Canada
Recruiting
Additional Information:
Study ID Numbers: 7999;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00067912
Other Depression Studies:
1. Treating Alcohol Use In Older Adults With Depression
2. Major depression and inflammatory risk markers for coronary heart disease
3. Electroconvulsive Therapy (ECT) Versus Drug Therapy for the Treatment of Depression
4. Treatment Resistant Depression Study
5. Treatment for Depressed Preadolescent Girls
Related Studies:
Other Depression Clinical Trials
Other Ontario Clinical Trials
Other Burlington Clinical Trials
Duloxetine vs. active comparator for the treatment of depression
|
|
|
|
|
|
|
|
